References
- Adamson G D. Treatment of uterine fibroids: Current findings with gonadotropin‐releasing hormone agonists. Am J Obstet Gynecol 1992; 166: 746–51
- Conn P M, Crowley W F. Gonadotropin‐releasing hormone and its analogues. N Engl J Med 1991; 324: 93–103
- Nakamura Y, Yoshimura Y, Yamada H, Ubukata Y, Ando M, Suzuki M. Treatment of uterine leiomyomata with a luteinizing hormone‐releasing hormone agonist: the possibility of nonsurgical management in selected perimenopau‐sal women. Fertil Steril 1991; 55: 900–5
- Friedman A J, Daly M, Juneau‐Norcross M, Rein M S, Fine C, Gleason R, et al. A prospective, randomized trial of gonadotropin‐releasing hormone agonist plus estrogen‐pro‐gestin or progestin ‘add‐back’ regimens for women with leiomyomata uteri. J Clin Endocrinol Metab 1993; 76: 1439–45
- Friedman A J, Lobel S M, Rein M S, Barbieri R L. Efficacy and safety considerations in women with uterine leiomyomas treated with gonadotropin‐releasing hormone agonists: The estrogen threshold hypothesis. Am J Obstet Gynecol 1990; 163: 1114–9
- Healy D L. The use of GnRH analogues in menorrhagia, contraception and uterine fibroids. The Current Status of GnRH Analogues, B Lunenfeld, V Insler. The Parthenon Publishing Group, Casterton Hall, Carnforth 1991; 33–40
- Lumsden M A, West C R, Baird D. Goserelin therapy before surgery for uterine fibroids. Lancet 1987; 1: 36–7
- Stovall T G, Ling F W, Henry L C, Woodruff M R. A randomized trial evaluating leuprolide acetate before hysterectomy as treatment for leiomyomas. Am J Obstet Gynecol 1991; 164: 1420–5
- Vercellini P, Bocciolone L, Colombo A, Vendola N, Mesch‐ia M, Bolis G. Gonadotropin releasing hormone agonist treatment before hysterectomy for menorrhagia and uterine leiomyomas. Acta Obstet Gynecol Scand 1993; 72: 369–73
- Geirsson R T. Intrauterine volume measurement techniques and uteroplacental growth. Ultrasound in Obstetrics and Gynecology, F A Chervenak, G C Isaacson, S Campbell. Little, Brown and Co., Boston 1993; 405–12
- Moghissi K S. Hormonal therapy before surgical treatment for uterine fibroids. Surg Gynecol Obstet 1991; 172: 497–502
- Dicker R C, Greenspan J R, Strauss L T, Cowart M R, Scally M J, Peterson H B, et al. Complications of abdominal and vaginal hysterectomy among women of reproductive age in the United States. Am J Obstet Gynecol 1982; 144: 841–8
- Easterday C L, Grimes D A, Riggs J. Hysterectomy in the United States. Obstet Gynecol 1983; 62: 203–12
- Fraser H M, Waxman J. Gonadotrophin releasing hormone analogues for gynaecological disorders and infertility. A real advance. Br Med J 1989; 298: 475–6
- Benagiano G, Morini A, Primiero F M. Fibroids: overview of current and future management. Br J Obstet Gynaecol 1992; 99(Suppl. 7)18–22
- Matta W HM, Stabile I, Shaw R W, Campbell S. Doppler assessment of uterine blood flow changes in patients with fibroids receiving the gonadotropin releasing hormone agonist, buserelin. Fertil Steril 1988; 49: 1083–5
- Gardner R L, Shaw R W. GnRH agonists and blood loss at surgery. Uterine Fibroids‐Time for Review, R W Shaw. The Parthenon Publishing Group, Casterton Hall, Carnforth 1992; 123–34
- Benagiano G, Primiero F M, Villani C. GnRH analogues in the management of uterine leiomyomas and other benign gynecological situations. GnRH Analogues ‐The State of the Art 1993, B Lunenfeld, V Insler. The Parthenon Publishing Group, Casterton Hall, Carnforth 1993; 55–85
- Baker V V, Shingleton H M. Incisions. Clin Obstet Gynecol 1988; 31: 700–11